Press Releases Legend Biotech Corporation

Equities

LEGN

US52490G1022

Biotechnology & Medical Research

Delayed Nasdaq Other stock markets 21:00:00 16/01/2026 GMT			5-day change	1st Jan Change
22.14 ^USD	+0.14%		-6.19%	+1.84%

01-14	Legend Biotech Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 09:00 AM
01-12	Legend Biotech highlights recent business updates at 44th annual J.P. Morgan Healthcare conference	RE

Press Releases

01-14	Legend Biotech : 2026 JP Morgan Presentation - Legend Biotech	PU
01-12	Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference	GL
01-12	Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference	AQ
12-17	Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference	GL
12-17	Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference	AQ
12-06	Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025	GL
11-27	Legend Biotech Awarded 2025 FIBA Foreign Investor of the Year by Flanders Investment & Trade	GL
11-13	Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia	GL
11-12	Legend Biotech : LEGN Q3 2025 Slides 11.5.2025	PU
11-12	Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights	GL
11-03	Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting	GL
29/10/25	Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results	GL
14/10/25	Cabaletta Bio Announces Appointment of Steve Gavel as Chief Commercial Officer and Award of Inducement Grant	AQ
27/08/25	NanoViricides Reports NV-387's Anti-Inflammatory Effects Could Combat Viral-Induced Cancer Resurgence	AQ
26/08/25	Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference	GL
18/08/25	Legend Biotech Appoints Carlos Santos as Chief Financial Officer	GL
18/08/25	Legend Biotech Appoints Carlos Santos as Chief Financial Officer	AQ
11/08/25	Legend Biotech : LEGN Q2 2025 Slides 8.5.25 10am	PU
11/08/25	Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights	GL
28/07/25	Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results	GL
04/06/25	Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI in Multiple Myeloma at 2025 ASCO Annual Meeting	AQ
03/06/25	Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting	GL
22/05/25	Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT	GL
19/05/25	Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting	GL
13/05/25	Legend Biotech : LEGN Q1 2025 Slides 5.9.25	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Press Releases Legend Biotech Corporation

Equities

LEGN

US52490G1022

Biotechnology & Medical Research

Press Releases

Filters